TriMark Publications Announces TriMark Molecular Diagnostics Conference 2008 in Boston on March 31st
TriMark Publications, a global leader in the biotechnology, healthcare and life sciences publishing, announces the TriMark Molecular Diagnostics Conference 2008 entitled: “Personalized Medicine through Genomic Analysis and Molecular Diagnostics.”
New York, NY (PRWEB) November 28, 2007
TriMark Publications (http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/)), a global leader in the biotechnology, healthcare and life sciences publishing, announces the TriMark Molecular Diagnostics Conference 2008 entitled:
"Personalized Medicine through Genomic Analysis and Molecular Diagnostics"
The Conference will be held on Monday, March 31, 2008 at Harvard Medical School located at the Joseph B. Martin Conference Center, 77 Avenue Louis Pasteur, Boston, Massachusetts, U. S.A. Registration details at http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/).
The TriMark Molecular Diagnostics 2008 Conference has been organized to provide a critical examination of the molecular diagnostics industry, as well as to provide insight from key industry leaders concerning cutting-edge molecular diagnostics technology. This conference will also provide an integral forum for leaders in molecular diagnostics, in vitro diagnostics and laboratories to share ideas, network with other delegates and advance understanding of the potential of new molecular diagnostics technologies. Speakers will include:
Kaiser Aziz, Ph. D., U. S. Food and Drug Administration (retired) Joseph Dooley, Ph. D., DABCC, FACB, Chief Executive Officer, TriMark Publications Helen Fernandes, Ph. D., Department of Pathology and Laboratory Medicine, New Jersey School of Medicine – University Hospital Harry Glorikian, Managing Partner, Scientia Advisors Graham Lidgard, Ph. D., Senior VP Research and Development, Nanogen Gwen McMillian, Ph. D., DABCC, University of Utah, ARUP Laboratory David Okrongly, Ph. D., Senior VP Molecular Diagnostics, Siemens
Who Should Attend:
Molecular diagnostics companies. In vitro diagnostic companies. Biotechnology companies. Medical devices manufacturers. Molecular diagnostic laboratorians
Leaders from the Following Areas Will Greatly Benefit from Attending:
Laboratory leaders. Hospital CFOs and CSOs. Molecular diagnostics and in vitro diagnostic companies. Business development. Strategic planning and development. Technology development. Marketing. Research and development.
A critical examination of key emerging technologies applicability to molecular diagnostics. Formation of successful alliances. Partnering of emerging technologies with molecular diagnostics. Transitioning from laboratory in vitro diagnostics to molecular diagnostics.
Questions Answered in the TriMark Conference:
What will the molecular diagnostics market be worth by the end of the decade? Which market segments will drive molecular diagnostics market growth? Which new technologies will reach the molecular diagnostics market in the next 2-3 years? How is technology innovation impacting the dynamics and ownership of the molecular diagnostics industry? What are the key challenges in gaining acceptance of new technologies by users, payers and regulators? How is technology innovation facilitating the transition of molecular diagnostics testing into standard healthcare practice?
Top Five Reasons To Attend the TriMark Conference:
Discover the molecular diagnostics sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success. Evaluate the competitive dynamics of the molecular diagnostics market and understand the changing relationship between IVD companies and the molecular diagnostics testing sector. Identify the key players in the molecular diagnostics market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players. Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users. Understand the factors driving growth of the molecular diagnostics market, which represents over 30% of global in vitro diagnostics sales.
Registration Fees for the Conference:
Early-Bird Registration Fee is $750 until February 29, 2008. Standard Registration Fee is $995 on and after March 1, 2008. At-the-Door Fee $1,295 on March 31, 2008 (subject to seating availability).
Register at http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/)
About TriMark Publications, LLC
Based in New York City, TriMark Publications is a global leader in biotechnology, healthcare and life sciences publishing. TriMark’s market research reports include the following:
Animal Health Products Antibacterials Markets Avian Influenza: The Threatening Pandemic Bioinformatics Markets Biomarker Technology Platforms for Cancer Diagnoses and Therapies Blood Gas Instrumentation Data Processing Blood Glucose Testing and Diabetes Management Cancer Diagnostic Testing World Markets Cancer Therapeutics Markets Cardiac Marker Diagnostic Testing Markets Cardiac Rhythm Management Devices World Markets Cell Therapy Markets Clinical Chemistry Analyzers Clinical Immunoanalyzer Markets Clinical Laboratory Testing Volume 1: Reagents and Instruments Clinical Laboratory Testing Volume 2: Business Strategies Cytology and HPV Testing World Markets Diabetes, Metabolic Syndrome and Cardiovascular Disease Disposable Medical Supplies Markets Disposable Syringe Markets DNA Sequencing and PCR Markets Drug Discovery Tools for High-Content Analysis Gene Expression Reagents Markets Genomics World Markets Hematology Analyzer Instrumentation and Reagent Markets High-Growth Diagnostic Tests Markets Home Healthcare Medical Devices Indian Pharmaceutical Industry Key Diagnostic Testing Markets Mammography World Markets Medical Imaging Markets Microarray Markets Microscopy Markets Molecular Diagnostics Markets Multi-Parameter Patient Monitor Markets Nuclear Cardiology Markets Nutraceuticals and Dietary Supplements Markets Over-the-Counter Diagnostic Products Markets Personalized Medicine Pharmacogenomic Testing Markets Point of Care Diagnostic Testing Sector Trends Point of Care Diagnostic Testing World Markets Positron Emission Tomography Markets RNA Interference Markets Stem Cell Markets Ultrasound Markets Veterinary Health Markets Women\'s Health: Diagnostic Tests
For more information, please visit http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/).
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMark Publications, LLC
Www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/)
# # #